The rapid rise in the stock market has investors in buying mood. Rising stocks are offering the best returns in today’s climate of …
While each investor has their own way of going about it, at the end of the day, the common theme unifying all is …
Applied Genetic Technologies Corp (NASDAQ:AGTC) shares lost 32% of their value today, after the gene therapy company provided a quarterly corporate update, showing that progress …
Applied Genetic Technologies Corp (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, …
On July 2 before market open, Biogen Inc (NASDAQ:BIIB) and Applied Genetic Technologies Corp (NASDAQ:AGTC) announced a broad collaboration and license agreement to …
The latest in the onslaught of biotech initial public offerings, Spark Therapeutics (ONCE) priced at $23 on Thursday evening. Twelve hours later, the stock opened at …
In a research report issued today, Roth Capital analyst Joseph Pantginis maintained a Buy rating on Applied Genetic Technologies (NASDAQ:AGTC) with a price …
In a research note issued earlier today, Wedbush analyst David Nierengarten maintained an Outperform and boosted his price target on Applied Genetic Technologies (AGTC) to $36.00 (from $24) …